NASDAQ · Biotechnology

Cypherpunk Technologies Inc. (CYPH) Stock

$2.94 +4.63% NASDAQ: CYPH Healthcare

Valuation

MetricValue
Price$2.94
Market Cap$313.00M
P/E Ratio5.14
P/B Ratio3.83
P/S Ratio325.27
EPS (TTM)$0.00
52-Week High$4.19
52-Week Low$0.39
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-0.57%
ROA-0.61%
ROCE-12.59%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio32.40

Annual Financials (USD)

Metric20212022202320242025
Revenue$2.0M$0$0$0$0
Operating Profit$-41.0M$-57.0M$-87.0M$-70.0M$-37.0M
Net Profit$-41.0M$-55.0M$-81.0M$-68.0M$5.0M
EPS$-4.73$-4.82$-3.98$-1.81$0.07
Op Margin-2761.7%————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$118.0M$58.0M$73.0M$49.0M$163.0M
Total Liabilities$10.0M$3.0M$13.0M$14.0M$10.0M
Cash$115.0M$21.0M$71.0M$47.0M$14.0M
Borrowings$0$1.0M$0$0$0

Latest News

Winklevoss-Backed Zcash Treasury Plunges Nearly 40% on ZEC Privacy Bug Concerns decrypt · Jun 5, 2026 Top Premarket Decliners MT Newswires · Jun 5, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-35.0M$-49.0M$-44.0M$-60.0M$-44.0M
Investing Cash Flow$0$0$49.0M$0$-97.0M
Financing Cash Flow$1.0M$0$0$-3.0M$0
Net Cash Flow$63.0M$-49.0M$5.0M$-23.0M$-33.0M
Free Cash Flow$-35.0M$-49.0M$-44.0M$-60.0M$-44.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-7.03
FCF Yield-8.38%
Quick Ratio79.19
Interest Coverage-740.62
Return 1Y128.15%
Return 3Y-75.74%
Return 5Y-94.54%

Ownership

Insiders Held8.44%
Institutions Held14.80%
Institutions Float Held16.16%
Institutional HolderSharesReport Date
Blackrock Inc.2,342,1742026-03-31
Vanguard Capital Management LLC1,818,4142026-03-31
Renaissance Technologies, LLC725,1202026-03-31
Geode Capital Management, LLC571,0682026-03-31
Vanguard Fiduciary Trust Co297,0862026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
APLMApollomics Inc. $21.50 -1.29% -2.84 $47.22M 0.00%
ASBPAspire-Lakewood Holdings, Inc. $8.30 +0.00% -1.03 $957588 0.00%
ATHAAthira Pharma, Inc. $6.75 -6.12% -0.28 $26.62M 0.00%
BCTXBriaCell Therapeutics Corp. $3.91 -0.26% -0.33 $34.02M 0.00%
CRISCuris, Inc. $0.67 -5.38% -0.06 $1.31M 0.00%

About Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc. is led by CEO Douglas E. Onsi, employs 52 people, headquartered in US, publicly traded since 2017.

Cypherpunk Technologies Inc. (CYPH) stock trades at $2.94 with a market capitalization of $313.00M. The stock is valued at a price-to-earnings (P/E) ratio of 5.14, price-to-book of 3.83, price-to-sales of 325.27. Over the past 52 weeks the stock has ranged between $0.39 and $4.19, and currently trades 29.8% below its 52-week high.

On profitability, Cypherpunk Technologies Inc. generates a return on equity (ROE) of -0.57%, return on capital employed of -12.59%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides